UVA-Riboflavin Crosslinking Treatment of Corneal Ectasia
Clinical trial NCT01325298 · UNKNOWN
Trial details
- NCT number
- NCT01325298
- Sponsor
- Mercy Center for Corrective Eye Surgery
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-01
- Primary completion
- 2014-03-01
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.